共 39 条
- [31] Design and discovery of novel monastrol-1,3,5-triazines as potent anti-breast cancer agent via attenuating Epidermal Growth Factor Receptor tyrosine kinaseScientific Reports, 7Jitendra Kumar SrivastavaGirinath G. PillaiHans Raj BhatAmita VermaUdaya Pratap Singh
- [32] Discovery of novel naphthalene-based diarylamides as pan-Raf kinase inhibitors with promising anti-melanoma activity: rational design, synthesis, in vitro and in silico screeningARCHIVES OF PHARMACAL RESEARCH, 2025, 48 (02) : 150 - 165Elkamhawy, AhmedAmmar, Usama M.Kim, MinkyoungGul, Anam RanaPark, Tae JungLee, Kyeong
- [33] Utilizing structure based drug design and metabolic soft spot identification to optimize the in vitro potency and in vivo pharmacokinetic properties leading to the discovery of novel reversible Bruton's tyrosine kinase inhibitorsBIOORGANIC & MEDICINAL CHEMISTRY, 2021, 44Hopkins, Brian T.Bame, ErisBell, NoahBohnert, TonikaBowden-Verhoek, Jon K.Bui, MinnaCancilla, Mark T.Conlon, PatrickCullen, PatrickErlanson, Daniel A.Fan, JunfaFuchs-Knotts, TarraHansen, StigHeumann, StaceyJenkins, Tracy J.Gua, ChuckLiu, YingLiu, YuTingLulla, MukushMarcotte, DouglasMarx, IsaacMcDowell, BobMertsching, ElisabethNegrou, EllaRomanowski, Michael J.Scott, DanielSilvian, LauraYang, WenjinZhong, Min
- [34] Discovery of novel pyrazole based Urea/Thiourea derivatives as multiple targeting VEGFR-2, EGFRWT, EGFRT790M tyrosine kinases and COX-2 Inhibitors, with anti-cancer and anti-inflammatory activitiesBIOORGANIC CHEMISTRY, 2024, 147Fadaly, Wael A. A.Nemr, Mohamed T. M.Kahk, Nesma M.
- [35] Discovery of a novel class anti-proliferative agents and potential inhibitors of EGFR tyrosine kinases based on 4-anilinotetrahydropyrido[4,3-d]pyrimidine scaffold: Design, synthesis and biological evaluationsBIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (15) : 4591 - 4607Zhang, YongZhang, KaiZhao, MengZhang, LixiaQin, MingzeGuo, ShuchunZhao, YanfangGong, Ping
- [36] Rational design and synthesis of a novel anti-leukemic agent targeting Bruton's tyrosine kinase (BTK), LFM-A13 [α-cyano-β-hydroxy-β-methyl-N-(2,5-dibromophenyl)propenamide]JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (14) : 9587 - 9599Mahajan, SGhosh, SSudbeck, EAZheng, YGDowns, SHupke, MUckun, FM
- [37] Rational design and synthesis of a novel anti-leukemic agent targeting Bruton's tyrosine kinase (BTK):: LFM-A13 [α-cyano-β-hydroxy-β-methyl-N-(2,3-dibromophenyl) propenamide].ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U1199 - U1199Uckun, FMSudbeck, EAZheng, YGMahajan, SGhosh, S
- [38] Discovery of novel naphthalene-based diarylamides as pan-Raf kinase inhibitors with promising anti-melanoma activity: rational design, synthesis, in vitro and in silico screeningDiscovery of novel naphthalene-based diarylamides as pan-Raf kinase inhibitorsA. Elkamhawy et al.Archives of Pharmacal Research, 2025, 48 (2) : 150 - 165Ahmed ElkamhawyUsama M. AmmarMinkyoung KimAnam Rana GulTae Jung ParkKyeong Lee
- [39] Type IIA - Type IIB protein tyrosine kinase inhibitors hybridization as an efficient approach for potent multikinase inhibitor development: Design, synthesis, anti-proliferative activity, multikinase inhibitory activity and molecular modeling of novel indolinone-based ureides and amidesEUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 163 : 37 - 53Eldehna, Wagdy M.El Kerdawy, Ahmed M.Al-Ansary, Ghada H.Al-Rashood, Sara T.Ali, Mamdouh M.Mahmoud, Abeer E.